- Home
- PSTV vs ICCM Comparison
PSTV vs ICCM Comparison
Compare PSTV & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- ICCM
- Stock Information
- Founded
- PSTV 1996
- ICCM 2006
- Country
- PSTV United States
- ICCM Israel
- Employees
- PSTV N/A
- ICCM N/A
- Industry
- PSTV Medical/Dental Instruments
- ICCM
- Sector
- PSTV Health Care
- ICCM
- Exchange
- PSTV Nasdaq
- ICCM Nasdaq
- Market Cap
- PSTV 61.1M
- ICCM 49.1M
- IPO Year
- PSTV N/A
- ICCM N/A
- Fundamental
- Price
- PSTV $0.51
- ICCM $0.72
- Analyst Decision
- PSTV Strong Buy
- ICCM Strong Buy
- Analyst Count
- PSTV 4
- ICCM 1
- Target Price
- PSTV $7.75
- ICCM $2.50
- AVG Volume (30 Days)
- PSTV 9.7M
- ICCM 788.9K
- Earning Date
- PSTV 10-30-2025
- ICCM 11-25-2025
- Dividend Yield
- PSTV N/A
- ICCM N/A
- EPS Growth
- PSTV N/A
- ICCM N/A
- EPS
- PSTV N/A
- ICCM N/A
- Revenue
- PSTV $5,258,000.00
- ICCM $2,787,000.00
- Revenue This Year
- PSTV $9.91
- ICCM $2.92
- Revenue Next Year
- PSTV $1.06
- ICCM $57.81
- P/E Ratio
- PSTV N/A
- ICCM N/A
- Revenue Growth
- PSTV N/A
- ICCM N/A
- 52 Week Low
- PSTV $0.16
- ICCM $0.53
- 52 Week High
- PSTV $2.31
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- PSTV 40.47
- ICCM 29.12
- Support Level
- PSTV $0.49
- ICCM $0.79
- Resistance Level
- PSTV $0.55
- ICCM $0.76
- Average True Range (ATR)
- PSTV 0.05
- ICCM 0.04
- MACD
- PSTV -0.02
- ICCM -0.01
- Stochastic Oscillator
- PSTV 10.97
- ICCM 14.18
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.